Physician profile
Eric F Bennett
NPI 1083155337
$2,966.64
in general payments reported to CMS, 2019-2025
40 companies · $1,124 in 2025
The $1,124 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $183 · 2021: $336 · 2022: $257 · 2023: $370 · 2024: $697 · 2025: $1,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,191.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $588.30 | 2021-2025 | Vraylar, Qulipta |
| Vanda Pharmaceuticals INC. | $245.08 | 2024-2025 | Fanapt |
| Novo Nordisk INC | $237.36 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $194.02 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $173.50 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $136.95 | 2020-2025 | Farxiga, Airsupra |
| Axsome Therapeutics, INC. | $114.30 | 2024-2025 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $110.35 | 2021-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Amgen INC. | $98.75 | 2021-2025 | Repatha, Otezla |
| Phathom Pharmaceuticals, INC. | $73.67 | 2025 | Voquezna |
| Edwards Lifesciences Corporation | $73.08 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Insulet Corporation | $72.86 | 2025 | Omnipod |
| Glaxosmithkline, LLC. | $67.71 | 2020-2023 | Trelegy Ellipta, Bexsero, Shingrix |
| Boston Scientific Corporation | $66.50 | 2022-2025 | General - Pain Management, Watchman Flx |
| Genzyme Corporation | $65.18 | 2021-2023 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.